FDA Approves Weight Loss Drugs Qsymia and Belviq: Are They Worth It?

Weight Loss Drugs Qsymia and Belviq Battling weight loss is an important step towards living a healthy long life. Visiting and getting the best attention from a medical weight loss clinic is very easy, affordable and important. You will get the care, attention and treatment needed. At Medifast Center, you will be introduced to two life changing drugs as well as other methods to fight obesity. Each method will be taken into account depending on your condition and preferences. The most important factor to them is your health and how you feel. After all, self-love and acceptance is key. We take very seriously health and that’s why we want to teach people to prevent drug addiction, learn more in this article https://firststepbh.com/blog/opioids-effects-around/.

The weight loss drugs Qsymia and Belviq give hope to obese patients, but questions of their effectiveness compared to diet and exercise remain. Glycine propionyl L-carnitine is also a popular supplement for those working out and watching their weight.

It’s not that diet pills are a dime a dozen, although a few are close; but there are many, many of them. Few of them are actually effective, or to put it another way, the U.S. Food and Drug Administration (FDA) approves very few of them.

In fact, the FDA has approved no new weight loss drugs in thirteen years. Now in short order, it has approved two drugs, Qsymia (Vivus Pharmaceutical) and Belviq (Arena Pharmaceuticals).

There are important differences and similarities between the two drugs which can be very clear with the use of a 10 panel drugs test. The FDA considers both of them ‘controlled substances,’ meaning they are sold under restrictions and controls similar to narcotics. They are also drugs that work by affecting the chemistry of the brain.

Qsymia is a combination of two relatively common and FDA approved drugs, phentermine and topiramate. Phentermine, an appetite suppressant, was part of the notorious diet drug fen-phen (fenfluramine phentermine).

The ‘fen’ part turned out to cause fatal lung and heart valve problems, which caused the widely sold drug from the market. Phentermine, the safe part of fen-phen, works by triggering the brain to release norepinephrine, which in turn increases output of the hormone leptin, an appetite regulator. Continue Reading

Changing the Message on Obesity with Lorcaserin

LorcaserinBy now, the facts are well known. One-third of Americans are obese. Doctors see its influence in a host of illnesses such as diabetes, heart disease and certain cancers. By any measure, obesity is an epidemic and it is spreading worldwide. So, what can people do about it? How about “Eat less, Move More?” Or maybe just take the latest obesity pill, Lorcaserin AKA Belviq .

Sounds good, but so far, the evidence shows those approaches are not working. That’s part of a new report by a team of researchers at the University of Colorado School of Medicine (Denver, USA), which suggests that the realities of obesity require a different emphasis. The report’s take-home message is “Move More, Eat Smarter.”

At the same time the Food and Drug Administration (FDA) has approved the first weight-loss drug since 1999. The drug, lorcaserin, which sells under the commercial name Belviq (Arena Pharmaceuticals), has passed through rigorous clinical trials and demonstrated it can produce weight loss of 5% of body weight for two-thirds of patients, and one-third lost 10%. Continue Reading